May 8 |
SpringWorks Therapeutics to Participate in the BofA Securities 2024 Health Care Conference
|
May 5 |
SpringWorks Therapeutics, Inc. (SWTX) Q1 2024 Earnings Call Transcript
|
May 5 |
SpringWorks Therapeutics, Inc. 2024 Q1 - Results - Earnings Call Presentation
|
May 3 |
Here's Why We're Not Too Worried About SpringWorks Therapeutics' (NASDAQ:SWTX) Cash Burn Situation
|
May 3 |
SpringWorks Therapeutics Inc (SWTX) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
|
May 2 |
SpringWorks Therapeutics GAAP EPS of -$1.18, revenue of $21M
|
May 2 |
SpringWorks Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Business Updates
|
May 1 |
SpringWorks Therapeutics Q1 2024 Earnings Preview
|
Apr 25 |
SpringWorks Therapeutics: Newly Commercial Stage, Fully Valued Biotech Means Steer Clear
|
Apr 24 |
SpringWorks Therapeutics Announces Abstracts Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
|